Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide acyclovir tablets. With a potential value of $8.5 million, the contract has a base year of performance from March 11, 2019 through March 10, 2020 plus four one-year option periods extending through March 2024. The contract facilitates delivery of standard pharmaceutical products to various government agencies on an as-needed basis....
The National Acquisition Center of the Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc. for the supply of Acyclovir 200mg Capsules. The contract has a period of performance from February 24, 2024 to February 23, 2025, with four one-year option periods, for a total ceiling value of $2,864,065.25. The contract aims to provide an uninterrupted source of Acyclovir 200mg Capsules in 100-count and 500-count bottles...
The federal agency, the Department of Veterans Affairs (VA) National Acquisition Center, awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc. (Golden State) to supply valacyclovir hydrochloride (valacyclovir HCL) tablets. The single-award contract has a one-year base period and four one-year option periods, with a total ceiling value of $33,080,061.65. Golden State, a for-profit manufacturer and distributor of pharmaceuticals, will provide the valacyclovir HCL...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. (GSMS) to supply 11,462 bottles of Tenofovir Disoproxil Fumarate 300mg tablets annually. The contract is for a base year with four one-year option periods, with a potential total value of $1,144,480.70. GSMS, a for-profit pharmaceutical manufacturer and distributor, will provide the tablets to the VA, Department of Defense (DoD), Bureau of...
Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center to provide mycophenolic acid tablets. The contract has a base year and four one-year options with a potential value of $19,275,127.05 and a period of performance through April 2024. As the prime contractor, Golden State Medical Supply will leverage its distribution infrastructure to supply mycophenolic acid tablets and other pharmaceutical...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. (a subsidiary of Gsms Inc.), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract, valued at up to $2,733,763.50, is for the provision of Dalfampridine SA Tablets over a base year and four one-year option periods. The contract was awarded on January 29, 2020 and allows for orders to be placed...
This federal Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The single-award contract has a ceiling value of $4,573,141.10 and a period of performance from November 5, 2023 to November 4, 2025, with four one-year option periods. The contract is for the supply of Donepezil tablets in various strengths and package sizes to support the...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to provide Ezetimibe tablets. The contract has a one-year base period and four one-year option periods, with a potential value of $21,089,456.25. Golden State Medical Supply will distribute the Ezetimibe tablets through the VA and Department of Defense Pharmaceutical Prime Vendor programs to VA hospitals, DoD treatment facilities, Bureau of...
This Indefinite Delivery Contract (IDC) valued at up to $5,743,180.85 was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc. (GSMS) on November 6, 2021. The contract has a one-year base period with four one-year option periods, for a total potential period of performance from November 6, 2021, to November 5, 2025. Under this IDC, GSMS will provide a variety of pharmaceutical products to the VA, Department of Defense (DoD), Bureau...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit manufacturer of pharmaceutical products, with a potential value of $3,966,704.10. The contract, which runs from June 20, 2023, to June 19, 2024, with four one-year option periods, is for the supply of Moxifloxacin HCL Ophthalmic Solution. The contract items will be distributed through the VA's and Department of...